US Pharmacopeia-Labmix24 Customer Information Event

Webinar registration | GLP-1 receptor agonists

Peptide-based drugs like GLP-1 receptor agonists are reshaping treatment for diabetes, obesity, and metabolic disorders. Ensuring structure, purity and amino acid sequence through robust peptide characterization is critical, as regulators require comprehensive profiling of known and unknown impurities to maintain product quality and compliance.

Labmix24 is sponsoring a special customer information event (webinar) on December 4th, 2025 from 13:00 - 14:00 (1-2 pm, CET). The event will be moderated by Nikhil Rautela from the US Pharmacopeia and will be held in English.

Join this webinar to learn how you can leverage USP Impurity ARMs to strengthen analytical rigor, enhance confidence in impurity profiling, and meet global quality expectations for GLP-1 therapies.